From: To: Cc: Subject: Date: BiaaarsUialui Paul Barrett Re: Cost Basis Tuesday. October 10. 2017 2:17:07 PM Cost basis of securities transferred in are as follows: Thank you Purchase Quantity A§FehPRVIEIP@R&ip Inc. (Formerly Dress Barn 1.3.11) Date 1/16/01 70,500 Cost 1,500,000 Foundation Medicine Inc 1/16/14 49.830 1,265,037 Sangamo Therapeutics Inc 5/28/13 50,000 422,214 Richard Kahn New York NY 10022 Phon Cel On Oct 10 2017 at 2:09 PM. < wrote: Hello, Richard. I wanted to follow up with you. My understanding is that there may be some questions around cost basis for the assets that you transferred over. How may I support you? <image003.jpg> CONFIDENTIAL SDNY_GM_000 12327 EFTA_00122976 EFTA01268400